Global T-Cell Immunotherapy Market Growth (Status and Outlook) 2025-2031

January 2025 | 89 pages | ID: G6D29F738588EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global T-Cell Immunotherapy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “T-Cell Immunotherapy Industry Forecast” looks at past sales and reviews total world T-Cell Immunotherapy sales in 2024, providing a comprehensive analysis by region and market sector of projected T-Cell Immunotherapy sales for 2025 through 2031. With T-Cell Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world T-Cell Immunotherapy industry.

This Insight Report provides a comprehensive analysis of the global T-Cell Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on T-Cell Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global T-Cell Immunotherapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for T-Cell Immunotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global T-Cell Immunotherapy.

This report presents a comprehensive overview, market shares, and growth opportunities of T-Cell Immunotherapy market by product type, application, key players and key regions and countries.

Segmentation by Type:

• CAR-T
• TCR
• TIL Therapies

Segmentation by Application:

• Stomach Cancer
• Lung Cancer
• Colorectal Cancer
• Esophagus Cancer
• Pancreatic Cancer
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Adaptimmune
• Altor Bioscience Corporation
• Cellectis
• Juno Therapeutics
• Kite Pharma
• Novartis
• Takara Bio
• Unum Therapeutics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global T-Cell Immunotherapy Market Size (2020-2031)
  2.1.2 T-Cell Immunotherapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for T-Cell Immunotherapy by Country/Region (2020, 2024 & 2031)
2.2 T-Cell Immunotherapy Segment by Type
  2.2.1 CAR-T
  2.2.2 TCR
  2.2.3 TIL Therapies
2.3 T-Cell Immunotherapy Market Size by Type
  2.3.1 T-Cell Immunotherapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global T-Cell Immunotherapy Market Size Market Share by Type (2020-2025)
2.4 T-Cell Immunotherapy Segment by Application
  2.4.1 Stomach Cancer
  2.4.2 Lung Cancer
  2.4.3 Colorectal Cancer
  2.4.4 Esophagus Cancer
  2.4.5 Pancreatic Cancer
  2.4.6 Others
2.5 T-Cell Immunotherapy Market Size by Application
  2.5.1 T-Cell Immunotherapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global T-Cell Immunotherapy Market Size Market Share by Application (2020-2025)

3 T-CELL IMMUNOTHERAPY MARKET SIZE BY PLAYER

3.1 T-Cell Immunotherapy Market Size Market Share by Player
  3.1.1 Global T-Cell Immunotherapy Revenue by Player (2020-2025)
  3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Player (2020-2025)
3.2 Global T-Cell Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 T-CELL IMMUNOTHERAPY BY REGION

4.1 T-Cell Immunotherapy Market Size by Region (2020-2025)
4.2 Global T-Cell Immunotherapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas T-Cell Immunotherapy Market Size Growth (2020-2025)
4.4 APAC T-Cell Immunotherapy Market Size Growth (2020-2025)
4.5 Europe T-Cell Immunotherapy Market Size Growth (2020-2025)
4.6 Middle East & Africa T-Cell Immunotherapy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas T-Cell Immunotherapy Market Size by Country (2020-2025)
5.2 Americas T-Cell Immunotherapy Market Size by Type (2020-2025)
5.3 Americas T-Cell Immunotherapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC T-Cell Immunotherapy Market Size by Region (2020-2025)
6.2 APAC T-Cell Immunotherapy Market Size by Type (2020-2025)
6.3 APAC T-Cell Immunotherapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe T-Cell Immunotherapy Market Size by Country (2020-2025)
7.2 Europe T-Cell Immunotherapy Market Size by Type (2020-2025)
7.3 Europe T-Cell Immunotherapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa T-Cell Immunotherapy by Region (2020-2025)
8.2 Middle East & Africa T-Cell Immunotherapy Market Size by Type (2020-2025)
8.3 Middle East & Africa T-Cell Immunotherapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL T-CELL IMMUNOTHERAPY MARKET FORECAST

10.1 Global T-Cell Immunotherapy Forecast by Region (2026-2031)
  10.1.1 Global T-Cell Immunotherapy Forecast by Region (2026-2031)
  10.1.2 Americas T-Cell Immunotherapy Forecast
  10.1.3 APAC T-Cell Immunotherapy Forecast
  10.1.4 Europe T-Cell Immunotherapy Forecast
  10.1.5 Middle East & Africa T-Cell Immunotherapy Forecast
10.2 Americas T-Cell Immunotherapy Forecast by Country (2026-2031)
  10.2.1 United States Market T-Cell Immunotherapy Forecast
  10.2.2 Canada Market T-Cell Immunotherapy Forecast
  10.2.3 Mexico Market T-Cell Immunotherapy Forecast
  10.2.4 Brazil Market T-Cell Immunotherapy Forecast
10.3 APAC T-Cell Immunotherapy Forecast by Region (2026-2031)
  10.3.1 China T-Cell Immunotherapy Market Forecast
  10.3.2 Japan Market T-Cell Immunotherapy Forecast
  10.3.3 Korea Market T-Cell Immunotherapy Forecast
  10.3.4 Southeast Asia Market T-Cell Immunotherapy Forecast
  10.3.5 India Market T-Cell Immunotherapy Forecast
  10.3.6 Australia Market T-Cell Immunotherapy Forecast
10.4 Europe T-Cell Immunotherapy Forecast by Country (2026-2031)
  10.4.1 Germany Market T-Cell Immunotherapy Forecast
  10.4.2 France Market T-Cell Immunotherapy Forecast
  10.4.3 UK Market T-Cell Immunotherapy Forecast
  10.4.4 Italy Market T-Cell Immunotherapy Forecast
  10.4.5 Russia Market T-Cell Immunotherapy Forecast
10.5 Middle East & Africa T-Cell Immunotherapy Forecast by Region (2026-2031)
  10.5.1 Egypt Market T-Cell Immunotherapy Forecast
  10.5.2 South Africa Market T-Cell Immunotherapy Forecast
  10.5.3 Israel Market T-Cell Immunotherapy Forecast
  10.5.4 Turkey Market T-Cell Immunotherapy Forecast
10.6 Global T-Cell Immunotherapy Forecast by Type (2026-2031)
10.7 Global T-Cell Immunotherapy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market T-Cell Immunotherapy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Adaptimmune
  11.1.1 Adaptimmune Company Information
  11.1.2 Adaptimmune T-Cell Immunotherapy Product Offered
  11.1.3 Adaptimmune T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Adaptimmune Main Business Overview
  11.1.5 Adaptimmune Latest Developments
11.2 Altor Bioscience Corporation
  11.2.1 Altor Bioscience Corporation Company Information
  11.2.2 Altor Bioscience Corporation T-Cell Immunotherapy Product Offered
  11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Altor Bioscience Corporation Main Business Overview
  11.2.5 Altor Bioscience Corporation Latest Developments
11.3 Cellectis
  11.3.1 Cellectis Company Information
  11.3.2 Cellectis T-Cell Immunotherapy Product Offered
  11.3.3 Cellectis T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Cellectis Main Business Overview
  11.3.5 Cellectis Latest Developments
11.4 Juno Therapeutics
  11.4.1 Juno Therapeutics Company Information
  11.4.2 Juno Therapeutics T-Cell Immunotherapy Product Offered
  11.4.3 Juno Therapeutics T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Juno Therapeutics Main Business Overview
  11.4.5 Juno Therapeutics Latest Developments
11.5 Kite Pharma
  11.5.1 Kite Pharma Company Information
  11.5.2 Kite Pharma T-Cell Immunotherapy Product Offered
  11.5.3 Kite Pharma T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Kite Pharma Main Business Overview
  11.5.5 Kite Pharma Latest Developments
11.6 Novartis
  11.6.1 Novartis Company Information
  11.6.2 Novartis T-Cell Immunotherapy Product Offered
  11.6.3 Novartis T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Novartis Main Business Overview
  11.6.5 Novartis Latest Developments
11.7 Takara Bio
  11.7.1 Takara Bio Company Information
  11.7.2 Takara Bio T-Cell Immunotherapy Product Offered
  11.7.3 Takara Bio T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Takara Bio Main Business Overview
  11.7.5 Takara Bio Latest Developments
11.8 Unum Therapeutics
  11.8.1 Unum Therapeutics Company Information
  11.8.2 Unum Therapeutics T-Cell Immunotherapy Product Offered
  11.8.3 Unum Therapeutics T-Cell Immunotherapy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Unum Therapeutics Main Business Overview
  11.8.5 Unum Therapeutics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1.T-Cell Immunotherapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2.T-Cell Immunotherapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of CAR-T
Table 4. Major Players ofTCR
Table 5. Major Players ofTILTherapies
Table 6.T-Cell Immunotherapy Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 7. GlobalT-Cell Immunotherapy Market Size byType (2020-2025) & ($ millions)
Table 8. GlobalT-Cell Immunotherapy Market Size Market Share byType (2020-2025)
Table 9.T-Cell Immunotherapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. GlobalT-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 11. GlobalT-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Table 12. GlobalT-Cell Immunotherapy Revenue by Player (2020-2025) & ($ millions)
Table 13. GlobalT-Cell Immunotherapy Revenue Market Share by Player (2020-2025)
Table 14.T-Cell Immunotherapy Key Players Head office and Products Offered
Table 15.T-Cell Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. GlobalT-Cell Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 19. GlobalT-Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Table 20. GlobalT-Cell Immunotherapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. GlobalT-Cell Immunotherapy Revenue Market Share by Country/Region (2020-2025)
Table 22. AmericasT-Cell Immunotherapy Market Size by Country (2020-2025) & ($ millions)
Table 23. AmericasT-Cell Immunotherapy Market Size Market Share by Country (2020-2025)
Table 24. AmericasT-Cell Immunotherapy Market Size byType (2020-2025) & ($ millions)
Table 25. AmericasT-Cell Immunotherapy Market Size Market Share byType (2020-2025)
Table 26. AmericasT-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 27. AmericasT-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Table 28. APACT-Cell Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 29. APACT-Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Table 30. APACT-Cell Immunotherapy Market Size byType (2020-2025) & ($ millions)
Table 31. APACT-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 32. EuropeT-Cell Immunotherapy Market Size by Country (2020-2025) & ($ millions)
Table 33. EuropeT-Cell Immunotherapy Market Size Market Share by Country (2020-2025)
Table 34. EuropeT-Cell Immunotherapy Market Size byType (2020-2025) & ($ millions)
Table 35. EuropeT-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & AfricaT-Cell Immunotherapy Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & AfricaT-Cell Immunotherapy Market Size byType (2020-2025) & ($ millions)
Table 38. Middle East & AfricaT-Cell Immunotherapy Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities ofT-Cell Immunotherapy
Table 40. Key Market Challenges & Risks ofT-Cell Immunotherapy
Table 41. Key IndustryTrends ofT-Cell Immunotherapy
Table 42. GlobalT-Cell Immunotherapy Market SizeForecast by Region (2026-2031) & ($ millions)
Table 43. GlobalT-Cell Immunotherapy Market Size Market ShareForecast by Region (2026-2031)
Table 44. GlobalT-Cell Immunotherapy Market SizeForecast byType (2026-2031) & ($ millions)
Table 45. GlobalT-Cell Immunotherapy Market SizeForecast by Application (2026-2031) & ($ millions)
Table 46. Adaptimmune Details, CompanyType,T-Cell Immunotherapy Area Served and Its Competitors
Table 47. AdaptimmuneT-Cell Immunotherapy Product Offered
Table 48. AdaptimmuneT-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Adaptimmune Main Business
Table 50. Adaptimmune Latest Developments
Table 51. Altor Bioscience Corporation Details, CompanyType,T-Cell Immunotherapy Area Served and Its Competitors
Table 52. Altor Bioscience CorporationT-Cell Immunotherapy Product Offered
Table 53. Altor Bioscience CorporationT-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Altor Bioscience Corporation Main Business
Table 55. Altor Bioscience Corporation Latest Developments
Table 56. Cellectis Details, CompanyType,T-Cell Immunotherapy Area Served and Its Competitors
Table 57. CellectisT-Cell Immunotherapy Product Offered
Table 58. CellectisT-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Cellectis Main Business
Table 60. Cellectis Latest Developments
Table 61. JunoTherapeutics Details, CompanyType,T-Cell Immunotherapy Area Served and Its Competitors
Table 62. JunoTherapeuticsT-Cell Immunotherapy Product Offered
Table 63. JunoTherapeuticsT-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. JunoTherapeutics Main Business
Table 65. JunoTherapeutics Latest Developments
Table 66. Kite Pharma Details, CompanyType,T-Cell Immunotherapy Area Served and Its Competitors
Table 67. Kite PharmaT-Cell Immunotherapy Product Offered
Table 68. Kite PharmaT-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Kite Pharma Main Business
Table 70. Kite Pharma Latest Developments
Table 71. Novartis Details, CompanyType,T-Cell Immunotherapy Area Served and Its Competitors
Table 72. NovartisT-Cell Immunotherapy Product Offered
Table 73. NovartisT-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Novartis Main Business
Table 75. Novartis Latest Developments
Table 76.Takara Bio Details, CompanyType,T-Cell Immunotherapy Area Served and Its Competitors
Table 77.Takara BioT-Cell Immunotherapy Product Offered
Table 78.Takara BioT-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79.Takara Bio Main Business
Table 80.Takara Bio Latest Developments
Table 81. UnumTherapeutics Details, CompanyType,T-Cell Immunotherapy Area Served and Its Competitors
Table 82. UnumTherapeuticsT-Cell Immunotherapy Product Offered
Table 83. UnumTherapeuticsT-Cell Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. UnumTherapeutics Main Business
Table 85. UnumTherapeutics Latest Developments



LIST OFFIGURES

Figure 1.T-Cell Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. GlobalT-Cell Immunotherapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6.T-Cell Immunotherapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7.T-Cell Immunotherapy Sales Market Share by Country/Region (2024)
Figure 8.T-Cell Immunotherapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. GlobalT-Cell Immunotherapy Market Size Market Share byType in 2024
Figure 10.T-Cell Immunotherapy in Stomach Cancer
Figure 11. GlobalT-Cell Immunotherapy Market: Stomach Cancer (2020-2025) & ($ millions)
Figure 12.T-Cell Immunotherapy in Lung Cancer
Figure 13. GlobalT-Cell Immunotherapy Market: Lung Cancer (2020-2025) & ($ millions)
Figure 14.T-Cell Immunotherapy in Colorectal Cancer
Figure 15. GlobalT-Cell Immunotherapy Market: Colorectal Cancer (2020-2025) & ($ millions)
Figure 16.T-Cell Immunotherapy in Esophagus Cancer
Figure 17. GlobalT-Cell Immunotherapy Market: Esophagus Cancer (2020-2025) & ($ millions)
Figure 18.T-Cell Immunotherapy in Pancreatic Cancer
Figure 19. GlobalT-Cell Immunotherapy Market: Pancreatic Cancer (2020-2025) & ($ millions)
Figure 20.T-Cell Immunotherapy in Others
Figure 21. GlobalT-Cell Immunotherapy Market: Others (2020-2025) & ($ millions)
Figure 22. GlobalT-Cell Immunotherapy Market Size Market Share by Application in 2024
Figure 23. GlobalT-Cell Immunotherapy Revenue Market Share by Player in 2024
Figure 24. GlobalT-Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Figure 25. AmericasT-Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 26. APACT-Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 27. EuropeT-Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 28. Middle East & AfricaT-Cell Immunotherapy Market Size 2020-2025 ($ millions)
Figure 29. AmericasT-Cell Immunotherapy Value Market Share by Country in 2024
Figure 30. United StatesT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 31. CanadaT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 32. MexicoT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 33. BrazilT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 34. APACT-Cell Immunotherapy Market Size Market Share by Region in 2024
Figure 35. APACT-Cell Immunotherapy Market Size Market Share byType (2020-2025)
Figure 36. APACT-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 37. ChinaT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 38. JapanT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 39. South KoreaT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast AsiaT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 41. IndiaT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 42. AustraliaT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 43. EuropeT-Cell Immunotherapy Market Size Market Share by Country in 2024
Figure 44. EuropeT-Cell Immunotherapy Market Size Market Share byType (2020-2025)
Figure 45. EuropeT-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 46. GermanyT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 47.FranceT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 48. UKT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 49. ItalyT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 50. RussiaT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & AfricaT-Cell Immunotherapy Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & AfricaT-Cell Immunotherapy Market Size Market Share byType (2020-2025)
Figure 53. Middle East & AfricaT-Cell Immunotherapy Market Size Market Share by Application (2020-2025)
Figure 54. EgyptT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 55. South AfricaT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 56. IsraelT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 57.TurkeyT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC CountriesT-Cell Immunotherapy Market Size Growth 2020-2025 ($ millions)
Figure 59. AmericasT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 60. APACT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 61. EuropeT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 62. Middle East & AfricaT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 63. United StatesT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 64. CanadaT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 65. MexicoT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 66. BrazilT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 67. ChinaT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 68. JapanT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 69. KoreaT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 70. Southeast AsiaT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 71. IndiaT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 72. AustraliaT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 73. GermanyT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 74.FranceT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 75. UKT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 76. ItalyT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 77. RussiaT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 78. EgyptT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 79. South AfricaT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 80. IsraelT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 81.TurkeyT-Cell Immunotherapy Market Size 2026-2031 ($ millions)
Figure 82. GlobalT-Cell Immunotherapy Market Size Market ShareForecast byType (2026-2031)
Figure 83. GlobalT-Cell Immunotherapy Market Size Market ShareForecast by Application (2026-2031)
Figure 84. GCC CountriesT-Cell Immunotherapy Market Size 2026-2031 ($ millions)